← All companies

PTCH

PureTech Health plc

PTCHF Pharmaceutical Preparations EDGAR ↗

$1.53

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$370M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.53 – $1.92

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K May 1, 2026 20-F Apr 29, 2026 6-K Apr 29, 2026 6-K Apr 29, 2026 6-K Dec 18, 2025 6-K Dec 10, 2025 6-K Aug 28, 2025 6-K Jul 16, 2025 6-K Jul 8, 2025 6-K Jun 16, 2025 20-F Apr 30, 2025 6-K Apr 30, 2025 6-K Apr 7, 2025 6-K Dec 16, 2024 6-K Oct 21, 2024 6-K Sep 27, 2024 6-K Aug 28, 2024 6-K Aug 28, 2024 6-K Aug 22, 2024 6-K Jun 24, 2024 6-K Jun 20, 2024 6-K Jun 13, 2024 6-K FORM 6-K Jun 6, 2024 6-K FORM 6-K Jun 4, 2024 6-K FORM 6-K May 29, 2024 6-K May 20, 2024 20-F Apr 25, 2024 6-K Apr 25, 2024 6-K Apr 9, 2024 6-K Mar 19, 2024 6-K Mar 18, 2024 6-K Mar 4, 2024 6-K Feb 5, 2024 6-K Jan 4, 2024 6-K Dec 20, 2023 6-K Dec 5, 2023 6-K Nov 2, 2023 6-K Oct 3, 2023 6-K Sep 6, 2023 6-K Aug 29, 2023